ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome (2019)
- Authors:
- USP affiliated authors: MENDONÇA, BERENICE BILHARINHO DE - FM ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidade: FM
- DOI: 10.1530/EC-19-0398
- Subjects: TRANSTORNOS DO DESENVOLVIMENTO SEXUAL; POLIMORFISMO; DENSIDADE ÓSSEA; MAMA; ÚTERO; TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS; RECEPTORES DE ESTEROIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Endocrine connections
- ISSN: 2049-3614
- Volume/Número/Paginação/Ano: v. 8, n. 11, p. 1513-1519, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SCALCO, Renata C et al. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome. Endocrine connections, v. 8, n. 11, p. 1513-1519, 2019Tradução . . Disponível em: https://doi.org/10.1530/EC-19-0398. Acesso em: 14 fev. 2026. -
APA
Scalco, R. C., Trarbach, E. B., Albuquerque, E. V. A., Homma, T. K., Inoue-Lima, T. H., Nishi, M. Y., et al. (2019). ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome. Endocrine connections, 8( 11), 1513-1519. doi:10.1530/EC-19-0398 -
NLM
Scalco RC, Trarbach EB, Albuquerque EVA, Homma TK, Inoue-Lima TH, Nishi MY, Mendonça BB de, Jorge AA de L. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome [Internet]. Endocrine connections. 2019 ; 8( 11): 1513-1519.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1530/EC-19-0398 -
Vancouver
Scalco RC, Trarbach EB, Albuquerque EVA, Homma TK, Inoue-Lima TH, Nishi MY, Mendonça BB de, Jorge AA de L. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome [Internet]. Endocrine connections. 2019 ; 8( 11): 1513-1519.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1530/EC-19-0398 - Pathogenic copy number variants in patients with congenital hypopituitarism associated with complex phenotypes
- Baixa estatura desproporcional por mutações no gene SHOX
- Novel Mutations (p.G6R and p.R511W) in IGF1R Gene in Children Born Small for Gestational Age (SGA) Without Catch-up Growth
- Growth Hormone (GH) Pharmacogenetics: Positive Influence of GH Receptor (GHR) Exon 3 Deleted Allele (d3) on First-year Growth Velocity and Final Height in Patients with Turner Syndrome (TS) Treated with Recombinant Human GH (rhGH)
- Autosomal recessive (type I) is more frequent than autosomal dominant (type II) isolated growth hormone deficiencyin acohort of Brazilian patients
- The Sitting Height/Height Ratio for Age in Healthy and Short Individuals and Its Potential Role in Selecting Short Children for SHOX Analysis
- Molecular analysis of brazilian patients with combined pituitary hormone deficiency and orthotopic posterior pituitary lobe reveals eight different PROP1 alterations with three novel mutations
- Evaluation of SHOX defects in the era of next-generation sequencing
- Association Study of GWAS-Derived Loci with Height in Brazilian Children: Importance of MAP3K3, MMP24 and IGF1R Polymorphisms for Height Variation
- Genetic diagnosis of congenital hypopituitarism by a target gene panel: novel pathogenic variants in GLI2, OTX2 and GHRHR
Informações sobre o DOI: 10.1530/EC-19-0398 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
